Pharmacogenomics of Antiplatelet Response - II (PARes-II)
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This clinical trial is examining the effect of 4-week aspirin therapy on platelet
transcriptome in persons at high-risk for myocardial infarction or stroke due to family
history of early-onset coronary artery disease.